Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 14/20 | 0.45 |
| ▸ | SLC5A1 | P13866 | 12/20 | 0.45 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3410877 | 0.78 | SLC5A1 (0.51) | SLC5A2SLC5A1CTSBRAB9ACYP19A1 | |
| SCHEMBL13553029 | 0.72 | SLC5A2 (0.72) | SLC5A2SLC5A1 | |
| SCHEMBL13553026 | 0.71 | SLC5A2 (0.56) | SLC5A2SLC5A1 | |
| SCHEMBL13554620 | 0.65 | SLC5A2 (0.55) | SLC5A2SLC5A1CYP19A1 | |
| SCHEMBL8377342 | 0.64 | SLC5A1 (0.70) | SLC5A2SLC5A1 | |
| SCHEMBL3413671 | 0.63 | SLC5A1 (0.58) | SLC5A2SLC5A1CTSBRAB9ACYP19A1 | |
| SCHEMBL1405119 | 0.63 | RAB9A (0.50) | RAB9ANPC1POLBACACB | |
| SCHEMBL27605521 | 0.63 | RAB9A (0.51) | RAB9ANPC1POLBACACB | |
| SCHEMBL338133 | 0.63 | CYP4F2 (0.51) | RAB9ANPC1POLB | |
| SCHEMBL13953725 | 0.62 | SLC5A2 (0.58) | SLC5A2SLC5A1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011039338-A2 | USE OF COMPOUNDS WITH SGLT-1/SGLT-2 INHIBITOR ACTIVITY FOR PRODUCING MEDICAMENTS FOR TREATMENT OF BONE DISEASES | SANOFI-AVENTIS (FR) | 2011-04-07 | — | — | WO | disclosed |
| US-7288528-B2 | Aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-10-30 | — | — | US | disclosed |
| US-7288528-B2 | Aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-10-30 | — | — | US | disclosed |